Skip to main content
. Author manuscript; available in PMC: 2020 Sep 15.
Published before final editing as: J Neurosurg. 2019 Mar 15:1–9. doi: 10.3171/2018.12.JNS182208

TABLE 1.

Summary of patient and dAVF features overall and by hemorrhagic presentation

Variable All (n = 147) Hemorrhagic (n = 36) Nonhemorrhagic (n = 111)
Age (mean ± SD) 56 ± 14 55 ± 12 56 ± 14
Female 61 (41.5) 11 (30.6) 50 (45.1)
Prior treatment for dAVF 73 (49.7) 18 (50.0) 55 (49.6)
 Any endovascular 66 (44.9) 15 (41.7) 51 (46.0)
  Endovasc ≥2 times 26 (17.7) 8 (22.2) 18 (16.2)
 Craniotomy 8 (5.4) 4 (11.1) 4 (3.6)
 SRS* 5 (3.7) 2 (5.6) 3 (2.7)
Patient presenting Sxs
 Headache 76 (51.7) 32 (88.9) 44 (39.6)
 Tinnitus 47 (32.0) 1 (2.8) 46 (41.4)
 Visual changes 29 (19.7) 5 (13.9) 24 (21.6)
 Asymptomatic 14 (9.5) 2 (5.6) 12 (10.8)
 NHNDs 29 (19.7) 0 (0.0) 29 (19.7)
 Neurological deficit 31 (21.1) 10 (27.8) 21 (18.9)
 Seizures 10 (6.8) 2 (5.6) 8 (7.2)
Spinal drainage 27 (19.9) 11 (30.6) 16 (14.4)
Associated edema 14 (8.8) 7 (19.4) 7 (6.3)
Multihole dAVF 55 (37.4) 13 (36.1) 42 (37.8)
Any cort venous drainage 78 (53.1) 28 (77.8) 50 (45.1)
Venous ectasia 36 (24.5) 13 (36.1) 16 (14.4)
Maximum dAVF diameter*
 Small (≤10 mm) 24 (24.0) 6 (16.7) 18 (16.2)
 Medium (11–20 mm) 45 (45.0) 11 (30.6) 34 (30.6)
 Large (>20 mm) 31 (31.0) 8 (22.2) 23 (20.7)
Location of dAVF
 Transverse/sigmoid 52 (35.4) 9 (25.0) 43 (38.7)
 Tentorial 40 (27.2) 12 (33.3) 28 (25.2)
 Carotid cavernous 21 (14.3) 3 (8.3) 18 (16.2)
 Torcular 12 (8.2) 6 (16.7) 6 (5.4)
 Anterior fossa 12 (8.2) 3 (8.3) 9 (8.1)
 Convexity 10 (6.8) 5 (13.8) 5 (4.5)
 Sagittal 8 (5.4) 3 (8.3) 5 (4.5)
 Middle fossa 7 (4.8) 1 (2.8) 6 (5.4)
Borden grade*
 1 49 (35.8) 5 (15.2) 44 (42.3)
 2 32 (23.4) 8 (24.3) 24 (23.1)
 3 56 (40.9) 20 (60.6) 26 (34.6)
Cognard classification*
 І 42 (30.9) 4 (12.1) 38 (36.9)
 ІІa 10 (7.4) 1 (3.0) 9 (8.7)
 ІІb 11 (8.1) 2 (6.1) 9 (8.7)
 ІІab 10 (7.4) 3 (9.1) 7 (6.8)
 ІІІ 8 (5.9) 3 (9.1) 5 (4.9)
 ІV 28 (20.6) 9 (27.3) 19 (18.5)
 V 27 (19.9) 11 (33.3) 16 (15.5)

Cort = cortical; endovasc = endovascular; SRS = stereotactic radiosurgery; Sxs = symptoms.

Unless stated otherwise, data are presented as the number (%) of patients.

*

Data only available for a portion of total patients (percentage of available patients shown).